TBX1 and neoplasm: We found that xenografts derived from co-transplantation with CAFs resulted in enhanced tumor volume and tumor weight compared with xenografts derived from A549 cells alone, suggesting that CAFs promoted NSCLC progression (Fig. 5B, and Fig. S7A).